Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.
Where to find us
Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com
The Highlights
Spain & India, working in the clinical development for a novel therapy against pediatric brain tumors
HighlightsGate2Brain part of the CDTI’s NEOTEC program
Highlights, NewsGate2Brain receives €2,5M funding from EIC to develop its technology
Highlights, Press releasesThree University of Barcelona spin-offs receive funding from Women TechEU
Highlights, NewsBStartup of Banco de Sabadell invests in Gate2Brain biotech
Funding & Breakthroughs, Highlights, Press releasesThe Mind the Gap program of Botín Foundation invests 1.5 million euros in three new biotech startups
Highlights, Media & Press, Press releasesSpain & India, working in the clinical development for a novel therapy against pediatric brain tumors
HighlightsGate2Brain part of the CDTI’s NEOTEC program
Highlights, NewsGate2Brain receives €2,5M funding from EIC to develop its technology
Highlights, Press releasesThree University of Barcelona spin-offs receive funding from Women TechEU
Highlights, NewsBStartup of Banco de Sabadell invests in Gate2Brain biotech
Funding & Breakthroughs, Highlights, Press releasesThe Mind the Gap program of Botín Foundation invests 1.5 million euros in three new biotech startups
Highlights, Media & Press, Press releasesNews & Media
Spain & India, working in the clinical development for a novel therapy against pediatric brain tumors
HighlightsGate2Brain obtains FDA Orphan Drug Designation for G2B-002
News, Press releases, timelineValidation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain
News, Press releasesClàudia Resa, G2B’s Doctoral Industrial PhD student : “I am proud have developed a new drug delivery system against childhood brain cancer”
News, TeamImitating nature to improve health
Interviews, News, Video ContentScience or science fiction? Research that reads like something out of a book
NewsGate2brain Achieves Emerging Company Certification from Enisa
News, timelineBioengineering the Future of Drug Delivery workshop – Porto
Events, NewsNew Trends in Brain Shuttle Peptides
Research & PublicationsGate2Brain at the 2nd Peptide-Based Therapeutics Summit | Boston
Events, NewsA Site-Specific MiniAp4−Trastuzumab Conjugate Prevents Brain Metastasis
Research & PublicationsInternations Women’s Day – TV3 Interview
Interviews, Video Content4YFN 2025
EventsKeystone Symposia on Drug Delivery to the Brain: Emerging Modalities
Events, NewsGate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric Oncology
Events